A Dreamliner in Air India colours at an airport in Washington
U.S. health regulators approved Indian drugmaker Dr Reddy's Laboratories' application to market generic version of AstraZeneca Plc's blood-pressure medicine Toprol-XL.Shares of the company were up 1.51 percent at Rs 1,671.
U.S. health regulators approved Indian drugmaker Dr Reddy's Laboratories' application to market generic version of AstraZeneca Plc's blood-pressure medicine Toprol-XL.
Shares of the company were up 1.51 percent at Rs 1,671.